The enhanced secretion of TGF‐β within the tumor microenvironment is associated to the recruitment of regulatory T cells via expression of FoxP3, which ultimately results in diminished cytotoxic T‐lymphocytes and in a reduced presence of DCs.15, 16. The gene discussed is TGFB1; the disease is neoplasm.